Distortion product otoacoustic emission data in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents in the pediatric HIV/AIDS cohort study

Pediatric HIV/AIDS Cohort Study (PHACS)

Research output: Contribution to journalArticle

Abstract

The effect of perinatal HIV infection and exposure on sub-clinical auditory function can be measured with distortion product otoacoustic emissions (DPOAEs). DPOAEs were obtained at 4 frequency bins (1, 2, 3 and 4 kHz) and categorized by a signal-to-noise ratio. HIV infection was not associated with poorer DPOAEs. Among HIV-infected children, HIV viral load ≥400 copies/mL had significantly lower odds of better DPOAEs.

Original languageEnglish (US)
Pages (from-to)276-278
Number of pages3
JournalPediatric Infectious Disease Journal
Volume34
Issue number3
DOIs
StatePublished - Mar 4 2015

Keywords

  • antiretroviral therapy
  • otoacoustic emissions
  • perinatal HIV exposure
  • perinatal HIV infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Distortion product otoacoustic emission data in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents in the pediatric HIV/AIDS cohort study'. Together they form a unique fingerprint.

  • Cite this